S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
S&P 500   5,254.35
DOW   39,807.37
QQQ   444.01
Stock market today: Asian shares are mostly higher after another set of Wall St records
Delta Airline’s Put Option Activity Isn’t Bad News
3 Value Stocks Too Small For Buffett’s Portfolio
Disney Stock Catches 3 Upgrades In a Single Week
7 Stocks That Will Drive the Weight Loss Drugs Market
Walgreens Boots Alliance: Deep Value With Nowhere to Go But Up
Krispy Kreme's Sweet Deal: McDonald's Partnership Sparks Growth?
NASDAQ:PLXP

PLx Pharma (PLXP) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
3,000 shs
Average Volume
12.96 million shs
Market Capitalization
$603,000.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
PLXP stock logo

About PLx Pharma Stock (NASDAQ:PLXP)

PLx Pharma, Inc. is a late-stage specialty pharmaceutical company, which engages in the development and commercialization of technology platform for approved drugs. It offers PLxGuard delivery system, which uses surface acting lipids, such as phospholipids and free fatty acids, to modify the physiochemical properties of various drugs with a targeted release to select portions of the gastrointestinal (GI) tract. The company was founded by Ronald R. Zimmerman on November 12, 2002 and is headquartered in Sparta, NJ.

PLXP Stock News Headlines

Protalix Biotherapeutics Inc (PLX)
Vertex Pharmaceuticals Inc VRTX
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
Vietnam National Petroleum Group (PLX)
PLx Pharma Inc (PLXPQ)
PLXPQ PLx Pharma Inc.
Central Banks Preparing for US Dollar Collapse?
China is spearheading this blatant de-dollarization push, dominating the physical gold market through massive central bank buying. Their ultimate goal? Ditching the greenback in favor of local BRICS currencies.
PLx Pharma Inc. Receives Nasdaq Delisting Notice
Short Volatility Alert: Plx Pharma Inc
PLx Pharma (PLXP) Q3 2022 Earnings Call Transcript
PLx Pharma down after Q3 revenue fell 94% Y/Y
Earnings Preview: PLx Pharma
PLXP Aug 2022 5.000 call
PLx Pharma downgraded at Oppenheimer after Q2 miss
PLx Pharma Q2 Loss Top Estimates, But Revenues Miss; Stock Down 15%
See More Headlines
Receive PLXP Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PLx Pharma and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/12/2021
Today
3/28/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:PLXP
Employees
16
Year Founded
2002

Profitability

Net Income
$-46,130,000.00
Net Margins
-606.91%
Pretax Margin
-606.91%

Debt

Sales & Book Value

Annual Sales
$4.54 million
Book Value
$1.30 per share

Miscellaneous

Free Float
26,530,000
Market Cap
$603,000.00
Optionable
Not Optionable
Beta
3.79

Social Links

10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

  • Natasha Giordano
    President, Chief Executive Officer & Director
  • Rita M. O'Connor
    CFO, Head-Manufacturing & Supply Chain
  • Mayme Lou Roettig
    Executive Medical Director
  • Thomas L. Long
    VP-Manufacturing & Technical Operations
  • Lawrence R. Perkins
    Chief Restructuring Officer

PLXP Stock Analysis - Frequently Asked Questions

How were PLx Pharma's earnings last quarter?

PLx Pharma Inc. (NASDAQ:PLXP) issued its quarterly earnings results on Friday, November, 12th. The biotechnology company reported ($0.37) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.46) by $0.09. The biotechnology company had revenue of $6.60 million for the quarter, compared to the consensus estimate of $4.10 million. PLx Pharma had a negative net margin of 606.91% and a negative trailing twelve-month return on equity of 291.11%. The company's revenue for the quarter was up 560.0% on a year-over-year basis. During the same quarter in the previous year, the company earned ($0.40) EPS.

What other stocks do shareholders of PLx Pharma own?
When did PLx Pharma IPO?

PLx Pharma (PLXP) raised $68 million in an IPO on Thursday, February 4th 2016. The company issued 3,800,000 shares at a price of $17.00-$19.00 per share. Raymond James served as the underwriter for the IPO and Maxim Group LLC and Janney Montgomery Scott were co-managers.

This page (NASDAQ:PLXP) was last updated on 3/29/2024 by MarketBeat.com Staff

From Our Partners